Meibomian Gland Dysfunction Treatment
Sponsor: Indiana University
Listed as NCT04229888, this NA trial focuses on Dry Eye and Meibomian Gland Dysfunction and remains completed. Sponsored by Indiana University, it has been updated 12 times since 2020, reflecting substantial change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
12 versions recorded-
Feb 2025 — Present [monthly]
Completed NA
-
Sep 2024 — Feb 2025 [monthly]
Completed NA
-
Jul 2024 — Sep 2024 [monthly]
Completed NA
-
Jan 2023 — Jul 2024 [monthly]
Completed NA
-
Dec 2022 — Jan 2023 [monthly]
Completed NA
▶ Show 7 earlier versions
-
Apr 2022 — Dec 2022 [monthly]
Completed NA
-
Sep 2021 — Apr 2022 [monthly]
Completed NA
Status: Recruiting → Completed
-
Mar 2021 — Sep 2021 [monthly]
Recruiting NA
-
Jan 2021 — Mar 2021 [monthly]
Recruiting NA
-
Sep 2020 — Jan 2021 [monthly]
Recruiting NA
-
Aug 2020 — Sep 2020 [monthly]
Recruiting NA
Status: Not Yet Recruiting → Recruiting
-
Feb 2020 — Aug 2020 [monthly]
Not Yet Recruiting NA
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Indiana University
For direct contact, visit the study record on ClinicalTrials.gov .